RapidLash

RapidLash is an American cosmetics brand specializing in eyelash and eyebrow enhancing serums. It launched in 2008 [2] and, according to a 2023 press release, was founded by International Research Laboratories in California [8]. The line is distributed by Rocasuba, Inc., based in Mashpee, Massachusetts on Cape Cod [7]. The brand markets itself as "the pioneer of eyelash enhancing serum" and remains active, with a current product range and ongoing retail distribution in the United States and other markets.

Its serums belong to a category of lash-conditioning products that has drawn regulatory attention: in 2011 the U.S. Food and Drug Administration issued a warning letter over the marketing and formulation of RapidLash and similar products [9].

RapidLash launched in 2008. The company describes its founding aim as helping "people enhance their natural beauty with simple, effective solutions that deliver visible results." Individual founders are not named in available sources. A 2023 press release attributes the brand's origin to International Research Laboratories, a group of chemists in California, while the current distributor, Rocasuba, Inc., operates from Massachusetts.

The brand's parent structure is recorded differently across sources. Rocasuba, Inc. is identified on the RapidLash site as the current distributor of the serums [7]. The earlier marketer, Lifetech Resources LLC, was the entity named by the FDA in its 2011 warning letter [9]. No single overarching corporate parent is disclosed; both entities are documented here for accuracy.

The line centers on four products: the RapidLash Eyelash Enhancing Serum, the RapidBrow Eyebrow Enhancing Serum, the RapidGlam Lash Enhancing Mascserum, and the RapidShield Eyelash Daily Conditioner. The eyelash and eyebrow serums are the brand's signature items.

At the core of the eyelash serum is a proprietary blend the company calls the Hexatein 1 Complex, described as "six highly effective ingredients designed to condition, moisturize and fortify" [5]. The formula combines polypeptides with biotin, panthenol, soybean oil and pumpkin seed extract, which the brand says work together to condition lashes and guard against breakage. The full ingredient list also includes isopropyl cloprostenate, a synthetic prostaglandin analog — the ingredient class central to the product's regulatory history (see Controversies).

RapidLash states that its serums are "ophthalmologist-tested and found to be safe and non-irritating," and that users may see "improvement in the appearance of eyelashes in as little as 4 weeks," with best results at eight weeks. The company describes its formulas as clinically tested and cruelty-free.

RapidLash positions itself around accessible, results-driven beauty, summarized in the tagline "Your Life, Your Pace, Your Lashes." In the 2023 anniversary release, chief executive Robert Trow framed the mission as a commitment to distribute accessible products "that work and make people feel confident" [8]. The serums are sold at prestige-tier prices through a multi-channel model spanning specialty, mass and online retail, including Ulta, Target, CVS and Amazon.

RapidLash products have collected numerous industry and consumer awards over more than a decade. These include a 2011 Cosmopolitan Beauty Awards win, the Cosmetic Executive Women UK Beauty Insiders' Choice and Woman & Home Best in Beauty the same year, and later recognition such as the ASCP Skin Deep Editor's Pick Awards (2018) and repeated wins in the Aestheticians' Choice Awards [3].

In the press, testers at Byrdie reported they "saw a real improvement in the strength and fullness of lashes" [10]. The brand also cites an interview in which actress Sydney Sweeney said her "eyelashes started growing like crazy" — a remark reported by Refinery29 rather than a paid endorsement [3].

In April 2011 the FDA issued a warning letter to Lifetech Resources LLC, then the marketer of RapidLash, over three eye-area products: the RapidLash Eyelash Renewal Serum, NeuLash and NeuveauBrow [9]. The agency treated the products as unapproved new drugs and misbranded cosmetics, citing both their growth-related claims and their use of the prostaglandin analog isopropyl cloprostenate. The FDA flagged potential risks associated with the ingredient, including eye irritation, changes in iris color, ocular inflammation and changes in intraocular pressure. RapidLash's current eyelash serum continues to list isopropyl cloprostenate among its ingredients [5].

RapidLash is an active brand. It marked 15 years in business in 2023 [8], its website carries a 2026 copyright, and its serums remain in distribution across US retailers, alongside international sites and a Nordic retail presence. The current catalogue spans the RapidLash, RapidBrow, RapidGlam and RapidShield products.